Such a cross-talk may lead to up-regulated expression of CCL2 and CCL5 in tumors expressing TNFα and/or IL-1β, thus possibly leading to increased tumor-supporting activities of the two chemokines in breast tumors (see Discussion, below). This evidence concerns the gene CCL2 and breast neoplasm.